AIMS: This study compared the results obtained by basic immunophenotyping of cerebrospinal fluid (CSF) cells by flow cytometry (FC) to the results of conventional cytology and evaluated the possibility of detailed analyses of CSF B-cell subpopulations. METHODS: Samples from 42 patients were examined by conventional cytology (native and/or pre-centrifuged CSF) and FC. The results from 15 patients without evidence of organic neurological disease were used to estimate reference ranges. RESULTS: Pre-centrifugated CSF had significantly higher cell yield on the cytologic slide, but cell subpopulation percentages were altered; the percentage of lymphocytes was significantly higher and monocytes significantly lower compared to both native CSF slides and FC. The percentage of granulocytes was higher in FC compared to cytology. For leukocyte count, the following reference ranges were estimated for Fuchs-Rosenthal chamber (FR) counting and FC, respectively: leukocytes ≤4.7/μL and ≤2.5/μL, lymphocytes ≤4.1/μL and ≤1.8/μL, monocytes ≤1.2/μL and ≤0.9/μL, and granulocytes 0/μL and ≤0.2/μL. The following reference ranges were estimated for basic subpopulations: T-lymphocytes 84.1-100%, B lymphocytes 0.0-1.5%, NK cells 0.0-6.3%, NKT cells 0-9.5%, and CD3+CD4+/CD3+CD8+ 0.8-4.9. Using a volume of 1.2-2.4 mL, the number of B lymphocytes was too low (<20) in samples with ≤2.7 cells/μL in the FR. CONCLUSIONS: Even normal CSF samples are amenable to basic mononuclear cell subpopulation analysis by FC. However, analysis of the B-cell subpopulations requires either a larger sample volume or selection of samples with ≥ 3 cells/μL.

Clinic of Neurology University Hospital Ostrava Czech Republic

Department of Biomedical Sciences Faculty of Medicine University of Ostrava Czech Republic

Department of Clinical Neurosciences Faculty of Medicine University of Ostrava Czech Republic

Institute of Laboratory Medicine University Hospital Ostrava Czech Republic

RECETOX Faculty of Science Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Strik H, Nagel I. Cell count and staining. In: Deisenhammer F, Sellebjerg F, Teunissen CE, Tumani H (Eds.) Cerebrospinal fluid in clinical neurology. Springer, Cham 2015, ISBN 978-3-319-01224-7: pp. 81-100. DOI

Tumani H, Petereit HF (Eds.) Lumbalpunktion und Liquordiagnostik. Guidelines of the German Society of Neurology, 2019. Available from: www.dgn.org [cited 2021 Dec 2]

Zeman D, Adam P, Kalistová H, Sobek O, Anděl J, Anděl M. Cerebrospinal fluid cytologic findings in multiple sclerosis. A comparison between patient subgroups. Acta Cytol 2000;45(1):51-9. PubMed DOI

Bielekova B, Pranzatelli MR. Promise, progress, and pitfalls in the search for central nervous system biomarkers in neuroimmunological diseases: A role for cerebrospinal fluid immunophenotyping. Semin Pediatr Neurol 2017;24:229-39. PubMed DOI

Alvermann S, Hennig C, Stüve O, Wiendl H, Stangel M. Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis. In search of biomarkers. JAMA Neurol 2014;71(7):905-12. PubMed DOI

Svenningsson A, Andersen O, Edsbagge M, Stemme S. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol 1995;63:39-46. PubMed DOI

de Graaf MT, Smitt PAES, Luitwieler RL, van Velzen C, van den Broek PDM, Kraan J, Gratama JW. Central memory CD4+ T cells dominate the normal cerebrospinal fluid. Cytometry Part B 2011;80B:43-50. PubMed DOI

Han S, Lin YC, Wu T, Salgado AD, Mexhitaj A, Wuest SC, Romm E, Ohayon J, Goldbach-Mansky R, Vanderver A, Marques A, Toro C, Williamson P, Cortese I, Bielekova B. Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases. J Immunol 2014;192:2551-63. PubMed DOI

de Graaf MT, de Jongste AH, Kraan J, Boonstra JG, Sillevis Smitt PA, Gratama JW. Flow cytometric characterization of cerebrospinal fluid cells. Cytometry Part B 2011;80B:271-81. PubMed DOI

Von Büdingen HC, Palanichamy A, Lehmann-Horn K, Michel BA, Zamvil SS. Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets. Eur Neurol 2015;73:238-46. PubMed DOI

De Graaf M, de Beukelaar J, Bergsma J, Kraan J, van den Bent M, Klimek M, van Norden Y, Kusuma A, Smitt PS, Gratama JW. B and T cell imbalances in CSF of patients with Hu-antibody associated PNS. J Neuroimmunol 2008;195:164-70. PubMed DOI

Bojková J. [Methods used in cerebrospinal fluid cytology]. Bachelor thesis. University of Ostrava, Faculty of Medicine, defended 6. 6. 2013.

Juhásová D. [Possibilities of increase of cell count in cytological slide of cerebrospinal fluid.] Bachelor thesis. University of Ostrava, Faculty of Medicine, defended 31. 5. 2018.

Zeman D, Kušnierová P, Hradílek P, Čábal M, Zapletalová O. Oligoclonal IgG and free light chains - comparison between agarose and polyacrylamide isoelectric focusing. Cesk Slov Neurol N 2019;82/115(1):68-75. DOI

Zeman D, Kušnierová P, Všianský F, Reguliová K, Škutová M, Woznicová I, Zapletalová O, Hradílek P. Cerebrospinal fluid oligoclonal IgM test in routine practice: Comparison with quantitative assessment of intrathecal IgM synthesis. Clin Chim Acta 2020,508:137-45. PubMed DOI

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BM, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162-73. PubMed DOI

CLSI (2008). Defining, establishing and verifying reference intervals in the clinical laboratory: approved guideline - third edition. CLSI document C28-A3. Wayne, PA. Clinical and Laboratory Standards Institute.

Mix E, Olsson T, Correale J, Baig S, Kostulas V, Olsson O, Link H. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 1990;79:21-7. PubMed DOI

Reiber H. Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994,122:189-203. PubMed DOI

Reiber H, Zeman D, Kušnierová P, Mundwiler E, Bernasconi L. Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams. Clin Chim Acta 2019;497:153-62. PubMed DOI

Rathbone E, Durant L, Kinsella J, Parker AR, Hassan-Smith G, Douglas MR, Curnow J. Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2018; 89(10):1044-9. PubMed DOI

Vafaii P, DiGiuseppe J. Detection of B-cell populations with monotypic light chain expression from patients with multiple sclerosis by polychromatic flow cytometry. Cytometry B Clin Cytom. 2014;86(2):106-10. PubMed DOI

Kleine TO. Cellular immune surveillance of central nervous system bypasses blood-brain barrier and blood-cerebrospinal-fluid barrier: Revealed with the new Marburg cerebrospinal-fluid model in healthy humans. Cytometry A 2015;87A:227-43. PubMed DOI

Kraan J, Gratama JW, Haioun C, Orfao A, Plonquet A, Porwit A, Quijano S, Stetler-Stevenson M, Subira D, Wilson W. Flow cytometric immunophenotyping of cerebrospinal fluid. Current Protocols in Cytometry 2008;6.24.1-6.25.16. PubMed DOI

Wurth S, Kuenz B, Bsteh G, Ehling R, Di Pauli F, Hegen H, Auer M, Gredler V, Deisenhammer F, Reindl M, Berger T. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study. PLoS ONE 2017;12(8):e0182462. PubMed DOI

Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Magnone MC, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009;73:1914-22. PubMed DOI

Girard S, Fenneteau O, Mestrallet F, Troussard X, Lesesve JF. Recommandations pour l'analyse du liquide céphalorachidien au cours des leucémies aiguës. Ann Biol Clin 2017;75(5):503-12. PubMed DOI

De Graaf MT, van den Broek PD, Kraan J, Luitwieler RL, van den Bent MJ, Boonstra JG, Schmitz PI, Gratama JW, Sillevis Smitt PA. Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time. J Neurol 2011;258:1507-12. PubMed DOI

Villar LM, Espiño M, Roldán E, Marín N, Costa-Frossard L, Muriel A, Álvarez-Cermeño JC. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes. Mult Scler 2011;17(6):690-4. PubMed DOI

Jones AP, Kermode AG, Lucas RM, Carroll WM, Nolan D, Hart PH. Circulating immune cells in multiple sclerosis. Clin Exp Immunol 2016;187:193-203. PubMed DOI

Posová H, Horáková D, Čapek V, Uher T, Hrušková Z, Havrdová E. Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients. BMC Neurology 2017;17:145. PubMed DOI

Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, Cesbron JY, Dumestre-Pérard C, Jacob MC. Novel strategy for phenotypic characterization of human B lymphocytes from precursors to effector cells by flow cytometry. PLoS ONE 2016;11(9):e0162209. PubMed DOI

Chovancová Z, Vlková M, Litzman J, Lokaj J, Thon V. Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination. Vaccine 2011;29(24):4142-50. PubMed DOI